CRISPR-targeting introduced a point mutation (CCC to ACT) that results in the amino acid substitution of proline with threonine in addition to a silent mutation. This mutation has been identified in patients with schizophrenia. (J:316319)
查看原文 参与反馈
CRISPR-targeting introduced a point mutation (CCC to ACT) that results in the amino acid substitution of proline with threonine in addition to a silent mutation. This mutation has been identified in patients with schizophrenia. (J:316319)